Dovato - Information on Uses and Dosage

Image credit: salcobrand.cl

What is Dovato used for?

What is Dovato? Dovato is a prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of HIV infection in adults who meet certain requirements, as determined by a health care provider. Dovato is a complete HIV treatment regimen and should not be used with other HIV medicines.

What are the side effects of Dovato?

This can cause serious or life-threatening side effects. DOVATO contains dolutegravir and lamivudine. Tell your doctor about any medicines or supplements you take. If you have a rash or allergic reaction symptoms, stop DOVATO and get medical help right away. Serious or life-threatening lactic acid buildup and liver problems can occur.

Can Dovato be used with other HIV medicines?

Dovato is a complete HIV treatment regimen and should not be used with other HIV medicines. Dovato contains two different medicines: dolutegravir and lamivudine.

How does Dovato treat HIV-1 infection?

Dovato combines dolutegravir (integrase strand transfer inhibitor) and lamivudine (nucleoside analogue reverse transcriptase inhibitor) to treat HIV-1 infection.

What is Dovato & how does it work?

DOVATO is a complete prescription regimen to treat HIV-1 in adults who have not received HIV-1 medicines in the past or to replace their current HIV-1 medicines when their doctor determines they meet certain requirements. What is the most important information I should know about DOVATO? Resistant HBV.

Does Dovato work in the pediatric population?

There are no clinical study data with DOVATO in the paediatric population. Although adolescents were not included in the pivotal GEMINI studies evaluating treatment with DOVATO, both dolutegravir and lamivudine are indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and adolescents.

What is Dovato pharmacokinetics?

DOVATO consists of 50 mg dolutegravir and 300 mg lamivudine which are approved doses for . Prior studies have shown that dolutegravir and lamivudine pharmacokinetic (PK) exposures in adolescents are sufficiently similar to those in adults.

What Is Dovato

1. https://www.dovato.com/
2. https://www.drugs.com/dovato.html
3. https://www.medicalnewstoday.com/articles/dovato
4. https://www.healthline.com/health/drugs/dovato
5. https://www.fda.gov/news-events/press-announcements/fda-approves-first-two-drug-complete-regimen-hiv-infected-patients-who-have-never-received
6. https://mydr.com.au/medicines/dovato/
7. https://clinicalinfo.hiv.gov/en/drugs/dolutegravir-lamivudine/patient
8. https://www.aidsmap.com/about-hiv/arv-factsheet/dovato
9. https://www.medicine.com/drug/dovato

Dovato Information

1. https://www.tga.gov.au/sites/default/files/auspar-dolutegravir-lamivudine-191204-pi.pdf
2. https://www.healthdirect.gov.au/medicines/brand/amt,1391721000168109/dovato-50-300
3. https://www.ema.europa.eu/en/medicines/human/EPAR/dovato
4. https://medsinfo.com.au/api/documents/Dovato_PI?format=pdf
5. https://apps.medicines.org.au/pdf.cfm?handle=vicdovat&drug=Dovato&src=Updated%20Products
6. https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/211994s018s019lbl.pdf